Kellton Tech Solutions Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 8:35 am

Competitors of Kellton Tech Solutions Ltd

All Competitor Stocks of Kellton Tech Solutions Ltd

Quarterly Result

Last Updated: August 20, 2025, 8:10 am

Below is a detailed analysis of the quarterly data for Kellton Tech Solutions Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 295.00 Cr.. The value appears strong and on an upward trend. It has increased from 286.00 Cr. (Mar 2025) to 295.00 Cr., marking an increase of 9.00 Cr..
• For Expenses, as of Jun 2025, the value is 260.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 257.00 Cr. (Mar 2025) to 260.00 Cr., marking an increase of 3.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 35.00 Cr.. The value appears strong and on an upward trend. It has increased from 29.00 Cr. (Mar 2025) to 35.00 Cr., marking an increase of 6.00 Cr..
• For OPM %, as of Jun 2025, the value is 12.00%. The value appears strong and on an upward trend. It has increased from 10.00% (Mar 2025) to 12.00%, marking an increase of 2.00%.
• For Other Income, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
• For Interest, as of Jun 2025, the value is 5.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 6.00 Cr. (Mar 2025) to 5.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 27.00 Cr.. The value appears strong and on an upward trend. It has increased from 21.00 Cr. (Mar 2025) to 27.00 Cr., marking an increase of 6.00 Cr..
• For Tax %, as of Jun 2025, the value is 16.00%. The value appears to be increasing, which may not be favorable. It has increased from 7.00% (Mar 2025) to 16.00%, marking an increase of 9.00%.
• For Net Profit, as of Jun 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from 19.00 Cr. (Mar 2025) to 23.00 Cr., marking an increase of 4.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.46. The value appears strong and on an upward trend. It has increased from 0.39 (Mar 2025) to 0.46, marking an increase of 0.07.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 5:02 am

Growth

Last Updated: September 5, 2025, 9:00 am

Balance Sheet

Last Updated: October 10, 2025, 2:23 pm

Below is a detailed analysis of the balance sheet data for Kellton Tech Solutions Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 49.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 49.00 Cr..
• For Reserves, as of Mar 2025, the value is 487.00 Cr.. The value appears strong and on an upward trend. It has increased from 395.00 Cr. (Mar 2024) to 487.00 Cr., marking an increase of 92.00 Cr..
• For Borrowings, as of Mar 2025, the value is 183.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 156.00 Cr. (Mar 2024) to 183.00 Cr., marking an increase of 27.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 70.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 61.00 Cr. (Mar 2024) to 70.00 Cr., marking an increase of 9.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 789.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 660.00 Cr. (Mar 2024) to 789.00 Cr., marking an increase of 129.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 63.00 Cr.. The value appears to be declining and may need further review. It has decreased from 69.00 Cr. (Mar 2024) to 63.00 Cr., marking a decrease of 6.00 Cr..
• For CWIP, as of Mar 2025, the value is 32.00 Cr.. The value appears strong and on an upward trend. It has increased from 18.00 Cr. (Mar 2024) to 32.00 Cr., marking an increase of 14.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 694.00 Cr.. The value appears strong and on an upward trend. It has increased from 573.00 Cr. (Mar 2024) to 694.00 Cr., marking an increase of 121.00 Cr..
• For Total Assets, as of Mar 2025, the value is 789.00 Cr.. The value appears strong and on an upward trend. It has increased from 660.00 Cr. (Mar 2024) to 789.00 Cr., marking an increase of 129.00 Cr..

Notably, the Reserves (487.00 Cr.) exceed the Borrowings (183.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Kellton Tech Solutions Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 8.18. This value is within the healthy range. It has increased from 6.58 (Mar 24) to 8.18, marking an increase of 1.60.
• For Diluted EPS (Rs.), as of Mar 25, the value is 8.15. This value is within the healthy range. It has increased from 6.58 (Mar 24) to 8.15, marking an increase of 1.57.
• For Cash EPS (Rs.), as of Mar 25, the value is 9.91. This value is within the healthy range. It has increased from 8.21 (Mar 24) to 9.91, marking an increase of 1.70.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 54.89. It has increased from 45.52 (Mar 24) to 54.89, marking an increase of 9.37.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 54.89. It has increased from 45.52 (Mar 24) to 54.89, marking an increase of 9.37.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 112.58. It has increased from 100.91 (Mar 24) to 112.58, marking an increase of 11.67.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 13.30. This value is within the healthy range. It has increased from 10.91 (Mar 24) to 13.30, marking an increase of 2.39.
• For PBIT / Share (Rs.), as of Mar 25, the value is 11.56. This value is within the healthy range. It has increased from 9.27 (Mar 24) to 11.56, marking an increase of 2.29.
• For PBT / Share (Rs.), as of Mar 25, the value is 9.49. This value is within the healthy range. It has increased from 7.38 (Mar 24) to 9.49, marking an increase of 2.11.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 8.18. This value is within the healthy range. It has increased from 6.57 (Mar 24) to 8.18, marking an increase of 1.61.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.18. This value is within the healthy range. It has increased from 6.57 (Mar 24) to 8.18, marking an increase of 1.61.
• For PBDIT Margin (%), as of Mar 25, the value is 11.81. This value is within the healthy range. It has increased from 10.81 (Mar 24) to 11.81, marking an increase of 1.00.
• For PBIT Margin (%), as of Mar 25, the value is 10.27. This value is within the healthy range. It has increased from 9.18 (Mar 24) to 10.27, marking an increase of 1.09.
• For PBT Margin (%), as of Mar 25, the value is 8.42. This value is below the healthy minimum of 10. It has increased from 7.31 (Mar 24) to 8.42, marking an increase of 1.11.
• For Net Profit Margin (%), as of Mar 25, the value is 7.26. This value is within the healthy range. It has increased from 6.51 (Mar 24) to 7.26, marking an increase of 0.75.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.26. This value is below the healthy minimum of 8. It has increased from 6.51 (Mar 24) to 7.26, marking an increase of 0.75.
• For Return on Networth / Equity (%), as of Mar 25, the value is 14.89. This value is below the healthy minimum of 15. It has increased from 14.43 (Mar 24) to 14.89, marking an increase of 0.46.
• For Return on Capital Employeed (%), as of Mar 25, the value is 18.72. This value is within the healthy range. It has increased from 18.30 (Mar 24) to 18.72, marking an increase of 0.42.
• For Return On Assets (%), as of Mar 25, the value is 10.10. This value is within the healthy range. It has increased from 9.69 (Mar 24) to 10.10, marking an increase of 0.41.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.09. This value is below the healthy minimum of 0.2. It has increased from 0.07 (Mar 24) to 0.09, marking an increase of 0.02.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.29. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.29.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.51. It has decreased from 1.56 (Mar 24) to 1.51, marking a decrease of 0.05.
• For Current Ratio (X), as of Mar 25, the value is 3.66. This value exceeds the healthy maximum of 3. It has increased from 3.36 (Mar 24) to 3.66, marking an increase of 0.30.
• For Quick Ratio (X), as of Mar 25, the value is 3.62. This value exceeds the healthy maximum of 2. It has increased from 3.36 (Mar 24) to 3.62, marking an increase of 0.26.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 6.40. This value is within the healthy range. It has increased from 5.79 (Mar 24) to 6.40, marking an increase of 0.61.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.93. This value is within the healthy range. It has increased from 4.49 (Mar 24) to 4.93, marking an increase of 0.44.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,170.86. It has increased from 1,050.06 (Mar 24) to 1,170.86, marking an increase of 120.80.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.07. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.07.
• For EV / EBITDA (X), as of Mar 25, the value is 9.03. This value is within the healthy range. It has decreased from 9.88 (Mar 24) to 9.03, marking a decrease of 0.85.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 1. It has decreased from 0.96 (Mar 24) to 0.94, marking a decrease of 0.02.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 1.95. This value is within the healthy range. It has decreased from 2.14 (Mar 24) to 1.95, marking a decrease of 0.19.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 1. It has decreased from 0.96 (Mar 24) to 0.94, marking a decrease of 0.02.
• For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 24) to 0.07, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness